lifestyle.floredechampagne.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
XVIVO Perfusion AB
XVIVO Presents Encouraging Results From First Clinical Trial Using Hypothermic Oxygenated Perfusion (HOPE) In Direct Procurement DCD Heart Transplantation
April 22, 2026
Preliminary One-Year Follow-up Data From the US Preserve Trial for XVIVO’s Heart Technology Presented at ISHLT in Toronto
April 22, 2026
Conference Call on Interim Report January-March 2026
April 17, 2026
The 12-Month Follow-up Results from XVIVO’s European Multicenter Heart Trial is Now Published in the European Heart Journal
April 16, 2026
Annual Report 2025
April 1, 2026
Notice To Attend the Annual General Meeting in XVIVO Perfusion Ab (Publ)
March 19, 2026
CORRECTION FROM SOURCE: The Nomination Committee’s Proposal for New Board Members
February 22, 2026
The Nomination Committee of XVIVO Perfusion AB (publ) Proposes Emil Billbäck and Anne-Karen Hunt as New Members of the Board of Directors
February 22, 2026
Management Change at XVIVO – CFO Transitions to New Role
February 21, 2026
Change of Date for Publication of the Interim Report January-March 2026
February 20, 2026
1
2
Next Page
→